Randa Tao
( out of 108 reviews )

Randa Tao, MD

Languages spoken: English

Clinical Locations

Radiation Oncology

801-581-2396

  • Specialties

    Patient Rating

    4.8 /5
    ( out of 108 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 13, 2023

    Very informative, listened and caring.

    August 08, 2023

    Very knowledgeable

    July 09, 2023

    Kind understanding and answered my questions.

    See More Patient Comments

  • Board Certification and Academic Information

    Academic Departments Radiation Oncology -Primary

    Education history

    Residency Radiation Oncology - University of Texas M.D. Anderson Cancer Center Resident
    Internal Medicine Preliminary Year - University of Texas Health Science Center at Houston and M.D. Anderson Cancer Center Intern
    Research Fellow Molecular Radiation Oncology - Howard Hughes Medical Institute-National Institutes of Health Research Fellow
    Medicine - Icahn School of Medicine at Mount Sinai M.D.
    Undergraduate Majors: Biology and Anthropology-Zoology; Minor: Mathematics - University of Michigan B.S.

    Selected Publications

    Journal Article

    1. Keltner SJ, Hallemeier C, Wang K, Tao R, Shah S, Heimbach J, Kharofa JR (2023). Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant. Am J Clin Oncol.
    2. Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao R (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leuk Lymphoma, 64(2), 356-363.
    3. Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney DK (2022). Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality. Cancer Med, 12(3), 2624-2636.
    4. Weil CR, Parsons MJ, Hutten RJ, Lew FH, Johnson SB, Gaffney DK, Tao R (2022). Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapy. Leuk Lymphoma, 63(12), 2847-2857.
    5. Fenlon J, Hutten R, Hu B, Shah H, Stephens DM, Johnson SB, Maity A, Gaffney DK, Tao R (2022). Radiation therapy for Early Stage Low Grade Follicular Lymphoma is Associated with Improved Overall Survival in the Rituximab Era. Leuk Lymphoma.
    6. Hutten RJ, Nelson G, Sarkar V, Johnson SB, Tao R, Hitchcock Y, Chan J, Schroeder J, Kokeny K (2022). Feasibility and Clinical Utility of a Workflow Interfacing Radiation Oncology Lung Stereotactic Body Radiation Therapy Treatment Planning and Diagnostic Radiology. Pract Radiat Oncol, 12(6), e512-e516.
    7. Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney DK (2022). Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leuk Lymphoma, 63(10), 2428-2435.
    8. Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe M (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572.
    9. Weil C, Parsons MP, Hutten RJ, Lew FH, Johnson SB, Gaffney DK, Tao R (2022). Patterns of Care and Outcomes of Early Stage I-II Hodgkin Lymphoma Treated with or without Radiation Therapy. Leuk Lymphoma.
    10. Rock CB, Chipman JJ, Parsons MW, Weil CR, Hutten RJ, Tao R, Tward JD, Shah HR, Hu B, Stephens DM, Gaffney DK (2022). Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. Adv Radiat Oncol, 7(6), 101035.
    11. Parsons M, Lloyd S, Johnson S, Scaife C, Soares H, Kim R, Kim R, Garrido-Laguna I, Tao R (2022). The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients. J Gastrointest Cancer, 1-9.
    12. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Chen W, Dabaja B, Daly ME, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Johnston PB, Kaminski MS, Kelsey CR, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, Metzger M, Morgan D, Mulroney C, Pullarkat ST, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Torka P, Winter JN, Yahalom J, Yang JC, Burns JL, Campbell M, Sundar H (2022). NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. J Natl Compr Canc Netw, 20(4), 322-334.
    13. Hu B, Patel JL, Tao R, Cannon RB, Monroe M, Goyal G (2022). Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation. J Natl Compr Canc Netw, 20(6), 618-621.
    14. Wen P, Dayyani F, Tao R, Zhong X (2021). Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry. Ann Transl Med, 10(2), 70.
    15. Odell DW, Albrechtsen RD, Sindt JE, Gole R, Brown S, Parsons MW, Paxton AB, Sarkar V, Lloyd S, Brogan SE, Tao R (2021). The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function. Neuromodulation, 24(7), 1204-1208.
    16. Kraus R, Tao R (2021). To Radiate, or Not to Radiate?  Implications of PET Biomarkers in Primary Mediastinal B-cell Lymphoma. Int J Radiat Oncol Biol Phys, 111(3), 594.
    17. Coffman A, Tao R, Cohan J, Huang L, Pickron B, Torgeson A, Lloyd S (2021). Factors Associated with the Refusal of Surgery and the Associated Impact on Survival in Patients with Rectal Cancer using the National Cancer Database. J Gastrointest Oncol, 12(4), 1482-1497.
    18. Bishop AJ, Livingston JA, Ning MS, Valdez ID, Wages CA, McAleer MF, Paulino AC, Grosshans DR, Woodhouse KD, Tao R, Roth ME, Gunn GB, McGovern SL (2021). Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys, 110(5), 1496-1504.
    19. De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ (2021). Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy. J Hepatocell Carcinoma, 8, 57-69.
    20. Parsons M, Lloyd S, Johnson S, Scaife C, Varghese T, Glasgow R, Garrido-Laguna I, Tao R (2020). Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival. Ann Surg Oncol, 28(2), 663-675.
    21. Parsons M, Tao R (2020). ASO Author Reflections: The Impact of Local Therapy on Non-metastatic Esophageal Cancer. Ann Surg Oncol, 27(Suppl 3), 818-819.
    22. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao R (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer Med, 9(21), 7954-7963.
    23. Sarkar V, Szegedi M, Paxton A, Nelson G, Rassiah-Szegedi P, Reddy CB, Tao R, Hitchcock YJ, Kokeny KE, Salter BJ (2020). Preliminary clinical experience with Calypso anchored beacons for tumor tracking in lung SBRT. Med Phys, 47(9), 4407-4415.
    24. Laggis CW, Lamb A, Secrest A, Ufkes N, Halwani A, Tao R, Gaffney D, Miles RR, Florell SR, Wada D (2020). Favorable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single-institution. J Eur Acad Dermatol Venereol.
    25. Wells SM, Boothe D, Ager BJ, Tao R, Gilcrease GW 3rd, Lloyd S (2020). Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer. Clin Colorectal Cancer, 19(2), 91-99.e1.
    26. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM, Benitez CM, Bierman PJ, Boughan KM, Dabaja B, Gordon LI, Hernandez-Ilizaliturri FJ, Herrera AF, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Lynch RC, Maddocks K, McConathy J, McKinney M, Metzger M, Morgan D, Mulroney C, Rabinovitch R, Rosenspire KC, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N (2020). Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(6), 755-781.
    27. Sarkar V, Szegedi M, Paxton A, Nelson G, Rassiah-Szegedi P, Reddy C, Tao R, Hitchcock Y, Kokeny K, Salter B (2020). Preliminary clinical experience with Calypso anchored beacons for tumor tracking in lung SBRT. Med Phys.
    28. Gruhl JD, Garrido-Laguna I, Francis SR, Affolter K, Tao R, Lloyd S (2020). The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer. Cancer Med, 9(5), 1703-1711.
    29. Baron MK, Osborn JD, Tao R, Lee CJ (2019). Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome. Leuk Lymphoma, 61(1), 231-233.
    30. Ager BJ, Wells SM, Gruhl JD, Stoddard GJ, Tao R, Kokeny KE, Hitchcock YJ (2019). Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer. Lung Cancer, 138, 6-12.
    31. Lloyd S, Baraghoshi D, Tao R, Garrido-Laguna I, Gilcrease GW 3rd, Whisenant J, Weis JR, Scaife C, Pickron TB, Huang LC, Monroe MM, Abdelaziz S, Fraser AM, Smith KR, Deshmukh V, Newman M, Rowe KG, Snyder J, Samadder NJ, Hashibe M (2019). Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival. Am J Clin Oncol, 42(4), 355-362.
    32. Tao R, Ager B, Lloyd S, Torgeson A, Denney M, Gaffney D, Kharofa J, Lin SH, Koong AC, Anzai Y, Hoffman JM (2018). Hypoxia Imaging in Upper Gastrointestinal Tumors and Application to Radiation Therapy. J Gastrointest Oncol, 9(6), 1044-1058.
    33. Sarkar V, Lloyd S, Paxton A, Huang L, Su FC, Tao R, Tward J, Zhao H, Salter B (2019). Daily breathing inconsistency in pancreas SBRT: a 4DCT study. J Gastrointest Oncol, 9(6), 989-995.
    34. Nevala-Plagemann C, Francis S, Cavalieri C, Tao R, Whisenant J, Glasgow R, Scaife C, Lloyd S, Garrido-Laguna I (2018). Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy. ESMO Open, 3(5), e000386.
    35. Jensen G, Tao R, Eng C, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Koay E, Taniguchi C, Krishnan S, Das P Co-first authors (2018). Treatment of primary rectal adenocarcinoma after prior pelvic radiation: the role of hyperfrationated accelerated reirradiation. Adv Radiat Oncol, 3(4), 595-600.
    36. Kokeny KE, Francis S, Tao R, Hitchcock YJ (2018). Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters. J Thorac Dis, 10(17), S2097-S2099.
    37. Prayongrat A, Tao R, Allen PK, Guha N, Rao G, Zhao Z, Li J, Brown PD, McGovern SL (2018). Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors. Neurooncol Pract, 009.
    38. Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N (2018). NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw, 16(3), 245-254.
    39. Francis S, Orton A, Stoddard G, Tao R, Hitchcock YJ, Akerley W, Kokeny KE (2017). Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer. J Clin Oncol, 36(4), 333-341.
    40. Torgeson A, Garrido-Laguna I, Tao R, Cannon GM, Scaife CL, Lloyd S (2018). Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. ESMO Open, 3(1), e000282.
    41. Torgeson A, Lloyd S, Boothe D, Cannon G, Garrido-Laguna I, Whisenant J, Lewis M, Kim R, Scaife C, Tao R (2017). Chemoradiation Therapy for Unresected Extrahepatic Cholangiocarcinoma: A Propensity Score-Matched Analysis. Ann Surg Oncol, 24(13), 4001-4008.
    42. Bishop AJ, Tao R, Guadagnolo BA, Allen PK, Rebueno NC, Wang XA, Amini B, Tatsui CE, Rhines LD, Li J, Chang EL, Brown PD, Ghia J (2017). Spine Stereotactic Radiosurgery for Metastatic Soft Tissue Sarcoma: Patterns of Failure and Radiation Treatment Volume Considerations. J Neurosurg Spine, 27(3), 303-311.
    43. Torgeson A, Lloyd S, Boothe D, Tao R, Whisenant J, Garrido-Laguna I, Cannon G (2017). Multi-agent Induction Chemotherapy Followed by Chemoradiation is Associated with Improved Survival in Locally Advanced Pancreatic Cancer. Cancer, 123(19), 3816-3824.
    44. Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ (2017). Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol, 4, 39-45.
    45. Tao R, Lloyd S, Burt L, Whisenant J, Garrido-Laguna I, Das P (2017). Pelvic Reirradiation for the Treatment of Locally Recurrent Rectal Cancer. Curr Colorectal Cancer Rep, 13, 175-182.
    46. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P (2017). Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol, 122(1), 146-151.
    47. Yamashita S, Koay EJ, Passot G, Raghav KP, Conrad C, Chun YS, Aloia TA, Tao R, Kaseb A, Javle M, Crane CH, Vauthey J (2017). Local Therapy Reduces the Risk of Liver Failure and Improves Survival in Patients with Intrahepatic Cholangiocarcinoma: a Comprehensive Analysis of 362 Consecutive Patients. Cancer, 123(8), 1354-1362.
    48. Cardenas CE, Mohamed A, Tao R, Wong AJ, Awan MJ, Kuruvila S, Aristophanous M, Gunn GB, Phan J, Beadle BM, Frank SJ, Garden AS, Morrison WH, Fuller CD, Rosenthal DI Co-first authors (2017). Prospective Qualitative and Quantitative Analysis of Real-time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys, 98(3), 532-540.
    49. Tao R, Bishop AJ, Brownlee Z, Allen PK, Settle SH, Chang EL, Wang X, Amini B, Tannir N, Tatsui C, Rhines LD, Brown PD, Ghia AJ (2016). Stereotactic radiation therapy for spinal metastases in the postoperative setting: a secondary analysis of mature phase I-II trials. Int J Radiat Oncol Biol Phys, 95(5), 1405-13.
    50. Swanick CW, Allen PK, Tao R, Olanrewaju AM, Sutton JR, Lin SH, Welsh J, Das P, Chang JY, Crane CH, Gomez D (2016). Incidence and Predictors of Chest Wall Toxicity after High-Dose Radiation Therapy in 15 Fractions. Pract Radiat Oncol, S1879-8500(16).
    51. Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J (2016). Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck, 38 Suppl 1, E580-7.
    52. Edson MA, Garden AS, Takiar V, Glisson BS, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Frank SJ, Shah SJ, Tao R, William WN, Weber RS, Rosenthal DI, Phan J (2016). Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head Neck, 38 Suppl 1, E2091-9.
    53. Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH (2016). Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J Clin Oncol, 34(3), 219-26.
    54. Bishop AJ, Gupta S, Cunningham MG, Tao R, Berner PA, Korpela SG, Ibbott GS, Lawyer AA, Crane CH (2015). Interstitial Brachytherapy for the Treatment of Locally Recurrent Anorectal Cancer. Ann Surg Oncol, 22 Suppl 3, S596-602.
    55. Bishop AJ, Tao R, Rebueno NC, Christensen EN, Allen PK, Wang XA, Amini B, Tannir NM, Tatsui CE, Rhines LD, Li J, Chang EL, Brown PD, Ghia AJ (2015). Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence. Int J Radiat Oncol Biol Phys, 92(5), 1016-26.
    56. Tao R, Allen PK, Rodriguez A, Shihadeh F, Pinnix CC, Arzu I, Reed VK, Oki Y, Westin JR, Fayad LE, Medeiros LJ, Dabaja B (2015). Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys, 92(1), 122-9.
    57. Tao R, Leclerc J, Yildiz K, Park SH, Jung B, Gius D, Ozden O (2015). Changes in gene expression in SIRT3 knockout liver cells. Turk J Biol, 39(3), 380-7.
    58. Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD (2014). Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. Radiother Oncol, 112(3), 321-5.
    59. Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D (2010). Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell, 40(6), 893-904.
    60. Rosenberg NA, Tao R (2008). Discordance of species trees with their most likely gene trees: the case of five taxa. Syst Biol, 57(1), 131-40.

    Review

    1. Torgeson A, Tao R, Garrido-Laguna I, Willen B, Dursteler A, Lloyd S (2019). Large database utilization in health outcomes research in pancreatic cancer: an update. [Review]. J Gastrointest Oncol, 9(6), 996-1004.
    2. Tao R, Vassilopoulos A, Parisiadou L, Yan Y, Gius D (2014). Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesis. [Review]. Antioxid Redox Signal, 20(10), 1646-54.
    3. Yang TJ, Tao R, Elkhuizen PH, van Vliet-Vroegindeweij C, Li G, Powell SN (2013). Tumor bed delineation for external beam accelerated partial breast irradiation: a systematic review. [Review]. Radiother Oncol, 108(2), 181-9.

    Book Chapter

    1. Tao R (2014). Orbital and Intraocular Primary Eye Lymphomas. In Hristov B, Lin SH, Christodouleas JP (Eds.), Radiation Oncology A Question-Based Review (2nd Edition). Philadelphia, PA: Wolters Kluwer Health.
    2. Tao R (2014). Ewing Sarcoma. In Hristov B, Lin SH, Christodouleas JP (Eds.), Radiation Oncology A Question-Based Review (2nd Edition). Philadelphia, PA: Wolters Kluwer Health.
    3. Tao R (2014). Thyroid Ophthalmopathy. In Hristov B, Lin SH, Christodouleas JP (Eds.), Radiation Oncology A Question-Based Review (2nd Edition). Philadelphia, PA: Wolters Kluwer Health.
    4. Tao R (2014). Orbital Pseudotumor. In Hristov B, Lin SH, Christodouleas JP (Eds.), Radiation Oncology A Question-Based Review (2nd Edition). Philadelphia, PA: Wolters Kluwer Health.
    5. Tao R, Yang TJ, Rhines LD, Brown PB, Settle SH (2013). Postoperative Spine Radiosurgery. In Sheehan JP, Gerszten PC (Eds.), Controversies in Stereotactic Radiosurgery. New York, NY: Thieme Medical Publishers.